Upgrade to SI Premium - Free Trial

Oramed Pharma (ORMP)

3.65 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31 May 19, 2026 5:08 PM - SEC Filing Form NT 10-Q ORAMED PHARMACEUTICALS For: Mar 31 May 15, 2026 4:10 PM - SEC Filing Form SCHEDULE 13G ORAMED PHARMACEUTICALS Filed by: Aquamarine Financial (Cayman) Ltd May 15, 2026 12:07 PM - SEC Filing Form 8-K ORAMED PHARMACEUTICALS For: Mar 25 March 31, 2026 4:21 PM - SEC Filing Form 4 ORAMED PHARMACEUTICALS For: Mar 30 Filed by: Kidron Miriam March 31, 2026 4:11 PM - SEC Filing Form 4 ORAMED PHARMACEUTICALS For: Mar 30 Filed by: KIDRON NADAV March 31, 2026 4:11 PM - SEC Filing Form 10-K ORAMED PHARMACEUTICALS For: Dec 31 March 26, 2026 5:15 PM - SEC Filing Lifeward closes strategic partnership with Oramed March 25, 2026 4:10 PM - StreetInsider Lifeward Successfully Closes on Strategic Partnership with Oramed March 25, 2026 4:10 PM - StreetInsider Form 4 ORAMED PHARMACEUTICALS For: Mar 17 Filed by: Kidron Miriam March 18, 2026 5:47 PM - SEC Filing Form 4 ORAMED PHARMACEUTICALS For: Mar 17 Filed by: KIDRON NADAV March 18, 2026 5:46 PM - SEC Filing Form 4 ORAMED PHARMACEUTICALS For: Mar 17 Filed by: Hexter Joshua March 18, 2026 5:46 PM - SEC Filing Form 4 ORAMED PHARMACEUTICALS For: Mar 17 Filed by: Gabay Avraham March 18, 2026 5:46 PM - SEC Filing Form 4 ORAMED PHARMACEUTICALS For: Mar 12 Filed by: KIDRON NADAV March 16, 2026 4:06 PM - SEC Filing Lifeward receives shareholder approval for Oramed partnership deal March 13, 2026 8:00 AM - StreetInsider Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company March 13, 2026 8:00 AM - StreetInsider Full Article List